Effect of olive oil phenols on the production of inflammatory mediators in freshly isolated human monocytes

Journal of Nutritional Biochemistry

Volumn 24, Issue 8, 2013, Pages 1513-1519

  Rosignoli, Patrizia ^a   Fuccelli, Raffaela ^a   Fabiani, Roberto ^a   Servili, Maurizio ^a   Morozzi, Guido ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Human monocytes; Hydroxytyrosol; PGE2; Superoxide anion; TNF

Indexed keywords

(3,4 DIHYDROXYPHENYL)ETHANOL ELENOLIC ACID; 4 HYDROXYPHENETHANOL ELENOLIC ACID; 7 HYDROXYSTAUROSPORINE; CYCLOOXYGENASE 2; CYTOCHROME C; HYDROXYTYROSOL; MESSENGER RNA; OLIVE OIL; PHENOL DERIVATIVE; PROSTAGLANDIN E2; SECOIRIDOID; SUPEROXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; TYROSOL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DONOR; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN EXPERIMENT; IMMUNOMODULATION; MONOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; REDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3,4-DHPEA; 3,4-DHPEA-EDA; CAT; CATALASE; COX2; CYCLOOXYGENASE2; DIALDEHYDIC FORM OF ELENOLIC ACID LINKED TO HYDROXYTYROSOL; DIALDEHYDIC FORM OF ELENOLIC ACID LINKED TO TYROSOL OR OLEOCANTHAL; H7; HUMAN MONOCYTES; HYDROXYSTAUROSPORINE; HYDROXYTYROSOL; P-HPEA; P-HPEA-EDA; PGE2; PHORBOL 12-MYRISTATE 13-ACETATE; PMA; PROSTAGLANDIN E2; REACTIVE OXYGEN SPECIES; ROS; SUPEROXIDE ANION; TNFΑ; TYROSOL;

ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; MONOCYTES; PHENOLS; PHENYLETHYL ALCOHOL; PLANT OILS; PYRANS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892444415     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.12.011     Document Type: Article

References (52)

1. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
2. Bradley J.R. TNF-mediated inflammatory disease. J Pathol 2008, 214:149-160.
3. Fabiani R., De Bartolomeo A., Rosignoli P., Sebastiani B., Morozzi G. Priming effect of benzo[a]pyrene on monocyte oxidative metabolism: possible mechanisms. Toxicol Lett 1999, 110:11-18.
4. Murakami A., Ohigashi H. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 2007, 121:2357-2363.
5. Wang D., DuBois R.N. Prostaglandins and cancer. Gut 2006, 55:115-122.
6. Covas M.I. Bioactive effects of olive oil phenolic compounds in humans: reduction of heart disease factors and oxidative damage. Inflammopharmacology 2008, 16(5):216-218. [Review].
7. Harwood J.L., Yaqoob P. Nutritional and health aspects of olive oil. Eur J Lipid Sci Technol 2002, 104:685-697.
8. Massaro M., De Caterina R. Vasculoprotective effects of oleic acid: epidemiological background and direct vascular antiatherogenic properties. Nutr Metab Cardiovasc Dis 2002, 12(1):42-51.
9. de Lorgeril M., Salen P. The Mediterranean-style diet for the prevention of cardiovascular diseases. Public Health Nutr 2006, 9(1A):118-123.
10. Granados-Pricipal S., Quiles J.L., Ramirez-Tortosa C.L., Sanchez-Rovira P., Ramirez-Tortosa M.C. Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev 2010, 68(4):191-206.
11. Bitler C.M., Viale T.M., Damaj B., Crea R. Hydrolyzed olive vegetation water in mice has anti-inflammatory activity. J Nutr 2005, 135:1475-1479.
12. 1 cell cycle arrest and apoptosis. Eur J Cancer Prev 2002, 11(4):351-358.
13. Fabiani R., De Bartolomeo A., Rosignoli P., Servili M., Montedoro G.F., Morozzi G. Effects of virgin olive oil phenols on proliferation, cell cycle and apoptosis of tumour cell lines. Eur J Public Health 2003, 13(4):121-122.
14. Nicholas C., Batra S., Vargo M.A., Voss O.H., Gavrilin M.A., Wewers M.D., et al. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol 2007, 179:7121-7127.
15. Zhang X., Cao J., Zhong L. Hydroxytyrosol inhibits pro-inflammatory cytokines, iNOS, and COX-2 expression in human monocytic cells. Naunyn Schmiedebergs Arch Pharmacol 2009, 379(6):581-586.
16. Maiuri M.C., De Stefano D., Di Meglio P., Irace C., Savarese M., Sacchi R., et al. Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. Naunyn Schmiedebergs Arch Pharmacol 2005, 371(6):457-465.
17. Gong D., Geng C., Jiang L., Cao J., Yoshimura H., Zhong L. Effects of hydroxytyrosol-20 on carrageenan-induced acute inflammation and hyperalgesia in rats. Phytother Res 2009, 23(5):646-650.
18. Sánchez-Fidalgo S., Sánchez de Ibargüen L., Cárdeno A., Alarcón de la Lastra C. Influence of extra virgin olive oil diet enriched with hydroxytyrosol in a chronic DSS colitis model. Eur J Nutr 2011, 51:497-506.
19. Fitó M., Cladellas M., de la Torre R., Martí J., Muñoz D., Schröder H., et al. SOLOS Investigators. Anti-inflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial. Eur J Clin Nutr 2008, 62(4):570-574.
20. Bogani P., Galli C., Villa M., Visioli F. Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 2007, 190(1):181-186.
21. Visioli F., Romani A., Mulinacci N., Zarini S., Conte D., Vincieri F.F., et al. Antioxidant and other biological activities of olive mill waste waters. J Agric Food Chem 1999, 47(8):3397-3401.
22. Bonaterra G.A., Heinrich E.U., Kelber O., Weiser D., Metz J., Kinscherf R. Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv(®)) in LPS-activated human monocytes and differentiated macrophages. Phytomedicine 2010, 17(14):1106-1113.
23. Fabiani R., Rosignoli P., Fuccelli R., Pieravanti F., De Bartolomeo A., Morozzi G. Involvement of hydrogen peroxide formation on apoptosis induction by olive oil phenolic compounds. Czech J Food Sci 2009, 27:S197-S199.
24. Fabiani R., Rosignoli P., De Bartolomeo A., Fuccelli R., Servili M., Morozzi G. The production of hydrogen peroxide is not a common mechanism by which olive oil phenols induce apoptosis on HL60 cells. Food Chem 2011, 125(4):1249-1255.
25. Fabiani R., Sepporta M.V., Rosignoli P., De Bartolomeo A., Crescimanno M., Morozzi G. Anti-proliferative and pro-apoptotic activities of hydroxytyrosol on different tumour cells: the role of extracellular production of hydrogen peroxide. Eur J Nutr 2011, 51:455-464.
26. Fabiani R., De Bartolomeo A., Rosignoli P., Servili M., Selvaggini R., Montedoro G.F., et al. Virgin olive oil phenols inhibit proliferation of human promyelocytic leukemia cells (HL60) by inducing apoptosis and differentiation. J Nutr 2006, 136(3):614-619.
27. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968, 21:77-89.
28. Hussain R.F., Nouri A.M., Oliver R.T. A new approach for measurement of cytotoxicity using colorimetric assay. J Immunol Methods 1993, 160:89-96.
29. Babior B.M., Kipnes R.S., Curnutte J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973, 52(3):741-744.
30. Raederstorff D. Antioxidant activity of olive polyphenols in humans: a review. Int J Vitam Nutr Res 2009, 79(3):152-165. [Review].
31. Lucas L., Russell A., Keast R. Molecular mechanisms of inflammation. Anti-inflammatory benefits of virgin olive oil and the phenolic compound oleocanthal. Curr Pharm Des 2011, 17(8):754-768.
32. Servili M., Esposto S., Fabiani R., Urbani S., Taticchi A., Mariucci F., et al. Phenolic compounds in olive oil: antioxidant, health and organoleptic activities according to their chemical structure. Inflammopharmacology 2009, 17(2):76-84. [Review].
33. Fabiani R., Sepporta M.V., Mazza T., Rosignoli P., Fuccelli R., De Bartolomeo A., et al. Influence of cultivar and concentration of selected phenolic constituents on the in vitro chemiopreventive potential of olive oil extracts. J Agric Food Chem 2011, 59(15):8167-8174.
34. Visioli F., Bellomo G., Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 1998, 247:60-64.
35. O'Dowd Y., Driss F., Dang P.M., Elbim C., Gougerot-Pocidalo M.A., Pasquier C., et al. Antioxidant effect of hydroxytyrosol, a polyphenol from olive oil: scavenging of hydrogen peroxide but not superoxide anion produced by human neutrophils. Biochem Pharmacol 2004, 68(10):2003-2008.
36. Gianni D., Taulet N., Zhang H., DerMardirossian C., Kister J., Martinez L., et al. A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. ACS Chem Biol 2010, 5(10):981-993.
37. Karlsson S., Nånberg E., Fjaeraa C., Wijkander J. Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br J Nutr 2010, 103(8):1102-1109.
38. Shah V.O., Ferguson J.E., Hunsaker L.A., Deck L.M., Vander Jagt D.L. Natural products inhibit LPS-induced activation of pro-inflammatory cytokines in peripheral blood mononuclear cells. Nat Prod Res 2010, 24(12):1177-1188.
39. Corona G., Deiana M., Incani A., Vauzour D., Dessì M.A., Spencer J.P. Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem Biophys Res Commun 2007, 362(3):606-611.
40. Corona G., Deiana M., Incani A., Vauzour D., Dessì M.A., Spencer J.P. Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1. Mol Nutr Food Res 2009, 53(7):897-903.
41. Lu Y., Wahl L.M. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J Immunol 2005, 175(8):5423-5429.
42. Zhang X., Cao J., Jiang L., Zhong L. Suppressive effects of hydroxytyrosol on oxidative stress and nuclear factor-kappaB activation in THP-1 cells. Biol Pharm Bull 2009, 32(4):578-582.
43. Carluccio M.A., Siculella L., Ancora M.A., Massaro M., Scoditti E., Storelli C., et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 2003, 23(4):622-629.
44. Beauchamp G.K., Keast R.S., Morel D., Lin J., Pika J., Han Q., et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 2005, 437(7055):45-46.
45. Khanal P., Oh W.K., Yun H.J., Namgoong G.M., Ahn S.G., Kwon S.M., et al. p-HPEA-EDA, a phenolic compound of virgin olive oil, activates AMP-activated protein kinase to inhibit carcinogenesis. Carcinogenesis 2011, 32(4):545-553.
46. Richard N., Arnold S., Hoeller U., Kilpert C., Wertz K., Schwager J. Hydroxytyrosol is the major anti-inflammatory compound in aqueous olive extracts and impairs cytokine and chemokine production in macrophages. Planta Med 2011, 77(17):1890-1897.
47. Page T.H., Turner J.J., Brown A.C., Timms E.M., Inglis J.J., Brennan F.M., et al. Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood. J Immunol 2010, 185(6):3694-3701.
48. Ratcliffe M.J., Walding A., Shelton P.A., Flaherty A., Dougall I.G. Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-alpha release from human alveolar macrophages. Eur Respir J 2007, 29:986-994.
49. Miro-Casas E., Covas M.I., Farre M., Fito M., Ortuño J., Weinbrenner T., et al. Hydroxytyrosol disposition in humans. Clin Chem 2003 Jun, 49(6 Pt 1):945-952.
50. Covas M.I., de la Torre K., Farre'-Albaladejo M., Kaikkonen J., Fito' M., Lo' pez-Sabater C., et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in human. Free Radic Biol Med 2006, 40:608-616.
51. Visioli F., Galli C., Bornet F., Mattei A., Patelli R., Galli G., et al. Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett 2000, 468(2-3):159-160.
52. Visioli F., Galli C., Grande S., Colonnelli K., Patelli C., Galli G., et al. Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration. J Nutr 2003, 133(8):2612-2615.